Cargando…
Imaging Lung Disease in Systemic Sclerosis
Interstitial lung disease and pulmonary hypertension (PH) are the most common cardiopulmonary findings in patients with systemic sclerosis (SSc). About two thirds of patients suffering from SSc develop scleroderma interstitial lung disease. PH is present in about 20% of SSc patients and is typically...
Autores principales: | Strollo, Diane, Goldin, Jonathan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845885/ https://www.ncbi.nlm.nih.gov/pubmed/20425026 http://dx.doi.org/10.1007/s11926-010-0095-0 |
Ejemplares similares
-
Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease
por: Martyanov, Viktor, et al.
Publicado: (2017) -
Diagnosis and monitoring of systemic sclerosis-associated
interstitial lung disease using high-resolution computed
tomography
por: Khanna, Dinesh, et al.
Publicado: (2022) -
Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis–associated interstitial lung disease trials
por: Khanna, Dinesh, et al.
Publicado: (2015) -
Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
por: Bergamasco, Aurore, et al.
Publicado: (2019) -
The Application of Fluorescence Optical Imaging in Systemic Sclerosis
por: Pfeil, Alexander, et al.
Publicado: (2015)